FDA Inspection 1050553 — Medpace, Inc.

Medpace, Inc. — FEI 3009316555

The FDA completed an inspection of Medpace, Inc. on Apr 20, 2018 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 20, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Additional details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745321 CFR 312.56(b)Investigator non-compliance
748221 CFR 312.50General responsibilities of sponsors

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.